Aehr Test's stock surged 8.35% during intraday trading on Wednesday, extending a strong rebound after breaking through previous resistance levels.
The rally was driven by oversold recovery demand following consecutive sharp declines that had largely exhausted selling pressure. Additionally, the company's $41 million AI chip testing order continues to provide robust fundamental support, accelerating market buying momentum.
The semiconductor equipment sector posted broad-based gains during the session, creating a favorable backdrop for Aehr Test's continued strength.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments